Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04447599
Other study ID # RC31/20/0001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 20, 2020
Est. completion date October 20, 2022

Study information

Verified date August 2021
Source University Hospital, Toulouse
Contact Nathalie NASR, MD
Phone 05 61 77 56 02
Email nasr.n@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to use a simple photography of conjunctival vessels to search for an association between conjunctival vessels abnormalities and the load of small vessel disease as quantified by MRI in patients with TIA s and minor strokes. The artificial intelligence (AI) tools will permit to classify abnormalities of conjunctival vessels that predict the load of small vessel disease in TIAs and strokes.


Description:

Small vessel disease is a risk factor of ischemic or hemorrhagic stroke and a direct cause of lacunar and hemorrhagic infarcts. Moreover, it is associated of cognitive impairment, like psychomotor retardation, deficits of attention, planning, and set-shifting, and dysexecutive syndrome. This disease affects the cerebral vessels of small diameters. Magnetic Resonance Imaging (MRI) is the gold standard for the diagnosis and the screening of this pathology. However it is an imaging with limit access and high cost. Vessels of bulbar conjunctiva have a small caliber like the small cerebral vessels and have the same origin: carotid arteries. They are easy to study with photography. The analysis of these vessels may be a new way of screening the small vessel disease, easier to use than MRI. Retinal vascularization is also easier to study with photography of fundus without dilatation by retinograph. Several studies already demonstrated an association between retinal abnormalities and load of small vessel disease. However, no relation was established between these modification and impairment of conjunctival vascularization in this cerebral pathology although those have the same arterial origin and vascular diameters. The strategy is to take a picture of temporal bulbar conjunctiva and fundus for patients with symptoms of TIA and minor stroke with all etiologies. Patients will be classified according to Fazekas staging and presence of lacunar infarcts. First, photography of bulbar conjunctiva will be analyzed by an artificial intelligence in " deep learning " to demonstrate a correlation between abnormalities of conjunctival vessels and staging of small cerebral disease. After that, photography of fundus will be analyzed with the same AI to search a correlation between conjunctival and retinal vascularization in small vessel disease. The present study will include patients with symptoms of TIAs and minor strokes coming at clinic of TIA in University Hospital Toulouse. A consultation by a neurologist will be done, than MRI will be prescribed for each of them. After a therapeutic care, they will go to the ophthalmologist for a photo of their bulbar conjunctival of each eye and photography of fundus without dilatation. The follow up will be realized the same day.


Recruitment information / eligibility

Status Recruiting
Enrollment 850
Est. completion date October 20, 2022
Est. primary completion date October 20, 2022
Accepts healthy volunteers No
Gender All
Age group 55 Years to 80 Years
Eligibility Inclusion Criteria: - Patients treated for a minor stroke or transient ischemic attack justifying an MRI. Exclusion Criteria: - Severe eye dryness with conjunctiva hyperhemia, - Taking eye treatments for glaucoma - Inflammatory or infectious eye damage resulting in conjunctiva hyperhemia: conjunctivitis, herpetic keratitis, ulcer, abscess, uveitis, peripheral ulcerative keratitis, interstitial keratitis, scleritis, episcleritis, pingueculitis, scarring eye pemphigoide, acute seizure by closing of the angle, - History of eye surgery. Among eye surgeries, those that can modify the conjunctiva are strabismus surgeries, glaucoma, conjunctiva resection surgery (pterygial or tumor) or wound surgery or finally recent cataract surgery (2 years). - Persons under the legal protection of adults (safeguarding justice, guardianship, curatorship, institutionalized, or under mandate of future protection) - Administrative problems: inability to give about informed information, no coverage by a social security plan, refusal to sign a consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
photography of conjunctival vessels
patient will have photo of their bulbar conjunctival of each eye and photography of fundus without dilatation

Locations

Country Name City State
France NASR Nathalie Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numbers of conjunctival vascular abnormalities Association between numbers of conjunctival vascular abnormalities and the load of small cerebral disease highlighted by neural network in " deep learning ". This outcome is collected after the end of the inclusion of all patients. day 1
Secondary Classification of different types of vascular abnormalities in different grades of small vessel disease Classification of different types of vascular abnormalities found in different grades of small vessel disease using the same neural network and also their association with cerebral macroangiopathy Day 1
Secondary Absence of difference between the 2 eyes Research for the absence of difference of abnormalities between both eyes Day 1
Secondary same stade of vascular abnormalities Association between abnormalities detected in fundus with retinograph and conjunctival vessels morphology in assessment of load of small vessel disease.Same sensitivity and specificity as conjunctiva photographs for each stage of vascular abnormalities Day 1
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT03685578 - CERENOVUS Neurothrombectomy Devices Registry
Recruiting NCT05591183 - CERENOVUS Neurothrombectomy Devices Registry
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Completed NCT02827825 - Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
Recruiting NCT02077582 - Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability N/A
Completed NCT01732679 - Sunnaas International Network´s Stroke Study N/A
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00311025 - Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications? Phase 1/Phase 2
Withdrawn NCT03804125 - A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Completed NCT05435404 - Qualitative Study Patient & Physician Experiences Botox COVID-19
Completed NCT03898960 - Post Marketing Study to Evaluate the NIMBUS Device
Not yet recruiting NCT06087094 - A Trial of HRS-7450 in Chinese Healthy Volunteers Phase 1
Completed NCT02207023 - Healthy Lifestyles After Stroke - Stroke Coach N/A
Active, not recruiting NCT02017574 - Motor Learning in Stroke Phase 0
Completed NCT01864382 - "Core Stability" Exercises to Improve Sitting Balance in Stroke Patients N/A
Completed NCT02002390 - Efficacy and Safety of FTY720 for Acute Stroke Phase 2
Recruiting NCT04157179 - Cerebral Oxygen Metabolism in Children N/A
Completed NCT03417349 - Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke